0
Skip to Content
Dopamine Agonist Action Group
Home
Team and Advisors
Aims and Objectives
Our Values
Types of Dopamine Agonists
Impulsive and Compulsive behaviour
Augmentation in RLS/PLMD
Dopamine Agonist Withdrawal Syndrome
Other side effects
Off-label use for depression
Health Unlocked Communities
2026 RLS Foundation Algorithm
Campaign updates
Parliamentary campaigning
How to help
Petition
Impulsive Podcast
Media Appearances
Other news
TV
Stories
Subscribe
Contact
Dopamine Agonist Action Group
Home
Team and Advisors
Aims and Objectives
Our Values
Types of Dopamine Agonists
Impulsive and Compulsive behaviour
Augmentation in RLS/PLMD
Dopamine Agonist Withdrawal Syndrome
Other side effects
Off-label use for depression
Health Unlocked Communities
2026 RLS Foundation Algorithm
Campaign updates
Parliamentary campaigning
How to help
Petition
Impulsive Podcast
Media Appearances
Other news
TV
Stories
Subscribe
Contact
Home
Folder: About
Back
Team and Advisors
Aims and Objectives
Our Values
Folder: Resources
Back
Types of Dopamine Agonists
Impulsive and Compulsive behaviour
Augmentation in RLS/PLMD
Dopamine Agonist Withdrawal Syndrome
Other side effects
Off-label use for depression
Health Unlocked Communities
2026 RLS Foundation Algorithm
Folder: Campaigns
Back
Campaign updates
Parliamentary campaigning
How to help
Petition
Folder: Media
Back
Impulsive Podcast
Media Appearances
Other news
TV
Stories
Subscribe
Contact

DAAG is a volunteer-led campaign working to improve awareness, informed consent, research, safeguarding and support for those affected by dopamine agonist side effects.

We do not provide medical advice. Patients should consult an appropriately qualified healthcare professional before making decisions regarding prescribed medication or treatment.

Campaign update: Constructive meeting with MHRA as part of review into dopamine agonists - our summary here
Logo for Dopamine Agonist Action Group (DAAG)